These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

905 related articles for article (PubMed ID: 26055905)

  • 1. Cross-talk between bile acids and intestinal microbiota in host metabolism and health.
    Nie YF; Hu J; Yan XH
    J Zhejiang Univ Sci B; 2015 Jun; 16(6):436-46. PubMed ID: 26055905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bile acid is a significant host factor shaping the gut microbiome of diet-induced obese mice.
    Zheng X; Huang F; Zhao A; Lei S; Zhang Y; Xie G; Chen T; Qu C; Rajani C; Dong B; Li D; Jia W
    BMC Biol; 2017 Dec; 15(1):120. PubMed ID: 29241453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered FXR signalling is associated with bile acid dysmetabolism in short bowel syndrome-associated liver disease.
    Pereira-Fantini PM; Lapthorne S; Joyce SA; Dellios NL; Wilson G; Fouhy F; Thomas SL; Scurr M; Hill C; Gahan CG; Cotter PD; Fuller PJ; Hardikar W; Bines JE
    J Hepatol; 2014 Nov; 61(5):1115-25. PubMed ID: 24999016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colon cancer checks in when bile acids check out: the bile acid-nuclear receptor axis in colon cancer.
    Tang Q; Evans RM
    Essays Biochem; 2021 Dec; 65(6):1015-1024. PubMed ID: 34414429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved glucose metabolism following bariatric surgery is associated with increased circulating bile acid concentrations and remodeling of the gut microbiome.
    Kaska L; Sledzinski T; Chomiczewska A; Dettlaff-Pokora A; Swierczynski J
    World J Gastroenterol; 2016 Oct; 22(39):8698-8719. PubMed ID: 27818587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired Intestinal Farnesoid X Receptor Signaling in Cystic Fibrosis Mice.
    Ikpa PT; Doktorova M; Meijsen KF; Nieuwenhuijze NDA; Verkade HJ; Jonker JW; de Jonge HR; Bijvelds MJC
    Cell Mol Gastroenterol Hepatol; 2020; 9(1):47-60. PubMed ID: 31470114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiota modification with probiotics induces hepatic bile acid synthesis via downregulation of the Fxr-Fgf15 axis in mice.
    Degirolamo C; Rainaldi S; Bovenga F; Murzilli S; Moschetta A
    Cell Rep; 2014 Apr; 7(1):12-8. PubMed ID: 24656817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer.
    Sun L; Cai J; Gonzalez FJ
    Nat Rev Gastroenterol Hepatol; 2021 May; 18(5):335-347. PubMed ID: 33568795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota-associated bile acid deconjugation accelerates hepatic steatosis in ob/ob mice.
    Park MY; Kim SJ; Ko EK; Ahn SH; Seo H; Sung MK
    J Appl Microbiol; 2016 Sep; 121(3):800-10. PubMed ID: 27111464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactoferrin promotes bile acid metabolism and reduces hepatic cholesterol deposition by inhibiting the farnesoid X receptor (FXR)-mediated enterohepatic axis.
    Ling CJ; Xu JY; Li YH; Tong X; Yang HH; Yang J; Yuan LX; Qin LQ
    Food Funct; 2019 Nov; 10(11):7299-7307. PubMed ID: 31626262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile Acid-Activated Receptors, Intestinal Microbiota, and the Treatment of Metabolic Disorders.
    Fiorucci S; Distrutti E
    Trends Mol Med; 2015 Nov; 21(11):702-714. PubMed ID: 26481828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Contributing Role of Bile Acids to Metabolic Improvements After Obesity and Metabolic Surgery.
    Fouladi F; Mitchell JE; Wonderlich JA; Steffen KJ
    Obes Surg; 2016 Oct; 26(10):2492-502. PubMed ID: 27475800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between bile salts, gut microbiota, and hepatic innate immunity.
    Schubert K; Olde Damink SWM; von Bergen M; Schaap FG
    Immunol Rev; 2017 Sep; 279(1):23-35. PubMed ID: 28856736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bile acids and FXR in functional gastrointestinal disorders.
    Mosińska P; Szczepaniak A; Fichna J
    Dig Liver Dis; 2018 Aug; 50(8):795-803. PubMed ID: 29908754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered enterohepatic circulation of bile acids in Crohn's disease and their clinical significance: a new perspective.
    Nolan JD; Johnston IM; Walters JR
    Expert Rev Gastroenterol Hepatol; 2013 Jan; 7(1):49-56. PubMed ID: 23265149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crosstalk between Bile Acids and Gut Microbiota and Its Impact on Farnesoid X Receptor Signalling.
    Wahlström A; Kovatcheva-Datchary P; Ståhlman M; Bäckhed F; Marschall HU
    Dig Dis; 2017; 35(3):246-250. PubMed ID: 28249261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.
    Sun R; Yang N; Kong B; Cao B; Feng D; Yu X; Ge C; Huang J; Shen J; Wang P; Feng S; Fei F; Guo J; He J; Aa N; Chen Q; Pan Y; Schumacher JD; Yang CS; Guo GL; Aa J; Wang G
    Mol Pharmacol; 2017 Feb; 91(2):110-122. PubMed ID: 27932556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice by intestinal-specific farnesoid X receptor reactivation.
    Degirolamo C; Modica S; Vacca M; Di Tullio G; Morgano A; D'Orazio A; Kannisto K; Parini P; Moschetta A
    Hepatology; 2015 Jan; 61(1):161-70. PubMed ID: 24954587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of different bile acids on the intestine through enterohepatic circulation based on FXR.
    Xiang J; Zhang Z; Xie H; Zhang C; Bai Y; Cao H; Che Q; Guo J; Su Z
    Gut Microbes; 2021; 13(1):1949095. PubMed ID: 34313539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
    Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
    Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.